Mutations in the LMNA gene encoding A-type lamins cause several diseases, including Emery -Dreifuss muscular dystrophy and Dunnigan-type familial partial lipodystrophy (FPLD). We analyzed differentiation of 3T3-L1 preadipocytes to adipocytes in cells overexpressing wild-type lamin A as well as lamin A with amino acid substitutions at position 482 that cause FPLD. We also examined adipogenic conversion of mouse embryonic fibroblasts lacking A-type lamins. Overexpression of both wild-type and mutant lamin A inhibited lipid accumulation, triglyceride synthesis and expression of adipogenic markers. This was associated with inhibition of expression of peroxisome-proliferator-activated receptor gamma 2 (PPARg2) and Glut4. In contrast, embryonic fibroblasts lacking A-type lamins accumulated more intracellular lipid and exhibited elevated de novo triglyceride synthesis compared with wild-type fibroblasts. They also had increased basal phosphorylation of AKT1, a mediator of insulin signaling. We conclude that A-type lamins act as inhibitors of adipocyte differentiation, possibly by affecting PPARg2 and insulin signaling.
INTRODUCTION
The nuclear lamina is a meshwork of intermediate filament proteins called lamins, which is primarily localized at the inner aspect of the nuclear envelope (1 -5) . In mammals, three genes encode seven lamin proteins that are expressed in somatic or germ cells. There are two B-type lamins in the nuclear lamina of somatic cells, lamin B1 and lamin B2. They are encoded by LMNB1 and LMNB2, respectively (6, 7) . Most differentiated somatic cells express three A-type lamins, lamin A, lamin C and lamin AD10, which are alternative splice variants of one gene, LMNA (8, 9) . Lamin A is synthesized as a precursor, prelamin A, which is modified by carboxymethylation and farnesylation and subsequently cleaved near its carboxyl terminus by the ZMPSTE24 endoprotease to yield mature lamin A (10, 11) .
The lamina has long been thought to provide structural support for the nuclear envelope (1, 12, 13) . Nuclear lamins have also been implicated in DNA replication (14, 15) and RNA polymerase-II-dependent transcription (16) . In 1999, mutations in LMNA were shown to cause autosomal-dominant Emery-Dreifuss muscular dystrophy, a disorder that affects cardiac and skeletal muscle (17) . This finding was followed by discoveries showing that mutations in A-type lamins cause several other diseases, some of which are relatively tissue-specific (for reviews, see 18, 19) .
The discoveries that different mutations in A-type lamins cause relatively tissue-specific disorders has led to the hypothesis that they may be essential for maintaining the differentiated state of post-embryonic somatic tissues (18) . This has been examined experimentally by taking advantage of C2C12 cells as an in vitro model for muscle differentiation. Reorganization and remodeling of A-type lamins occurs during differentiation of C2C12 cells (20 -22) . Expression of lamin A mutants that cause autosomal-dominant EmeryDreifuss muscular dystrophy in C2C12 myoblasts inhibits their in vitro differentiation into myotubes (21, 23) . Although human subjects with Emery -Dreifuss muscular dystrophy and Lmna null mice that develop a phenotype with similarities to this human condition are born with normally developed # The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org striated muscles, both develop cardiomyopathy and muscular dystrophy after birth (24, 25) . This suggests that myoblast differentiation may be inadequate to replace damaged or lost tissue.
Another relatively tissue-specific disease caused by autosomal-dominant inherited mutations in A-type lamins is Dunnigan-type familial partial lipodystrophy (FPLD; OMIM #151660) (26 -28) . FPLD appears to primarily affect adipocytes and is characterized by progressive loss of subcutaneous fat from upper and lower extremities usually at the onset at puberty (29 -31) . Excess adipose tissue can accumulate in the face and neck, causing a double chin or a Cushingoid appearance. Affected individuals have high concentrations of serum-free fatty acids and triglycerides, low serum concentrations of high-density lipoprotein, low serum leptin concentrations, glucose intolerance, insulin resistance and often diabetes mellitus. Some affected individuals have skeletal muscle hypertrophy (32, 33) . Loss of A-type lamin function does not appear to be responsible for this condition, as Lmna null mice do not develop partial lipodystrophy (34) .
Although mutations in A-type lamins cause a diseasecharacterized loss of peripheral fat, the effects of A-type lamins on adipocyte differentiation have not been addressed. We, therefore, took advantage of 3T3-L1 cells, an established preadipose line that resembles fibroblasts and can be manipulated to differentiate in vitro into adipocytes (35 -37) , to assess the effect of lamin A overexpression on adipocyte differentiation. We also examined the potential of fibroblasts lacking A-type lamins (25) to become fat-containing cells. Our results suggest that A-type lamins are inhibitors of adipocyte differentiation and have implications for understanding how mutations in these proteins cause FPLD.
RESULTS

Generation of preadipocyte cell lines overexpressing lamin A
To investigate the effect of lamin A overexpression on adipogenesis, we generated mouse 3T3-L1 cell lines stably expressing wild-type lamin A or lamin A with arginine at position 482 changed to glutamine (R482Q) or tryptophan (R482W). These amino acid substitutions are found in human subjects with FPLD. In their undifferentiated state, 3T3-L1 cells resemble fibroblasts but are capable of differentiating into lipid-containing adipocytes upon treatment of a confluent monolayer with insulin, dexamethasone and isobutylmethylxanthine (IBMX).
We made three clonal lines each of 3T3-L1 cells transfected with plasmid vector alone and with plasmids encoding flagtagged human wild-type lamin A, flag-tagged human lamin A R482Q and flag-tagged human lamin A R482W. We also made three clonal lines of cells transfected with plasmid encoding flag-tagged human emerin, a control inner nuclear membrane protein. Antibiotic-resistant clones were selected and checked for expression of flag-tagged lamin A (Fig. 1A) and flag-tagged emerin (Fig. 1B) mRNAs by semi-quantitative reverse transcriptase -polymerase chain reaction (RT -PCR). Relative expression of flag-tagged lamin and emerin mRNAs in different clones was similar ( Fig. 1A and B) . Flag-tagged wild-type and mutant lamin A as well as emerin were targeted to the nuclear periphery, where they colocalized with endogenous lamin B1, as seen by double immunofluorescence microscopy with anti-lamin B1 and anti-flag antibodies (Fig. 1C) . (Fig. 3A) . However, de novo triglyceride synthesis was hindered in cells expressing flag-tagged wild-type and mutant lamin A protein, as shown by only a small amount of tritium incorporation into the triglyceride fraction of extracted cellular lipids (Fig. 3A) . Incorporation of tritium into the phospholipid fraction was not altered in any of the examined cell lines, implying that general oleate metabolism is not affected by lamin A overexpression (Fig. 3B) . From these results, we conclude that cell lines stably expressing flag-tagged human lamin A are defective in de novo triglyceride synthesis, which is responsible for their inability to accumulate intracellular lipid. (Fig. 4) . In contrast, SREBP-1C mRNA was detected in all examined cell lines (Fig. 4) . b-Actin mRNA, a positive control, was detected at similar levels in all tested cell lines. Our results show that overexpression of lamin A is associated with decreased PPARg2 and Glut4 mRNA levels but normal expression of SREBP-1C mRNA after treatment with insulin, dexamethasone and IBMX. 
Expression of
Lamin A overexpression in non-clonal 3T3-L1 populations inhibits adipogenesis
To make sure that the inability of 3T3-L1 preadipocytes to differentiate into adipocytes is a consequence of lamin A overexpression and not merely stable transfection and selection of cells containing certain protein-expressing plasmids, we infected populations of 3T3-L1 cells with retroviral constructs encoding flag-tagged human wild-type or mutant lamin A. Bicystronic retroviruses were constructed in which one internal ribosomal entry site drives expression of either green fluorescent protein (GFP) alone or GFP and flagtagged human wild-type or mutant lamin A. GFP-expressing cells were collected by fluorescence-activated cell sorting and grown without antibiotic selection. The presence of human lamin A mRNA was detected by RT -PCR (Fig. 5A ).
The nuclear rim localization of the flag-tagged lamins was confirmed by immunofluorescence microscopy with antibodies against the flag epitope (Fig. 5B ). We then assessed the ability of cells expressing flag-tagged lamins to accumulate lipid upon treatment with insulin, dexamethasone and IBMX. Figure 5C shows that lipid accumulation was apparent after treatment in cells that expressed GFP alone but not cells that expressed GFP together with wild-type or mutant lamin A. Hence, overexpression of lamin A protein in nonclonal populations of 3T3-L1 cells inhibits lipid accumulation.
To be sure that addition of the flag epitope to lamin A is not responsible for blocking adipogenic conversion of 3T3-L1 cells, we expressed untagged human lamin A using the same methods and these cells also did not differentiate (data not shown).
Embryonic fibroblasts from Lmna 2/2 mice differentiate into fat-containing cells more readily than embryonic fibroblasts from wild-type mice As overexpression of lamin A inhibited adipogenic conversion, we hypothesized that fibroblasts lacking lamins A and C would more readily become fat-containing cells than their wild-type counterparts. Primary embryonic fibroblasts from Lmna þ/þ and Lmna 2/2 mice were grown to confluency and were either left untreated or treated with medium containing insulin, dexamethasone, IBMX and troglitazone for 2 days and then transferred to medium supplemented with insulin and troglitazone. Accumulated intracellular lipids were visualized by Oil Red-O. After 9 days of treatment, embryonic fibroblast lacking A-type lamins become fat-containing cells more readily compared with fibroblasts with A-type lamins (Fig. 6A ). Untreated Lmna 2/2 and Lmna þ/þ accumulated very little intracellular lipid (Fig. 6A) . Semi-quantitative analysis showed that amount of Oil Red-O extracted from Lmna 2/2 fibroblasts incubated with insulin, dexamethasone, IBMX and troglitazone was approximately 3-fold higher than that extracted from similarly treated Lmna þ/þ cells or untreated fibroblasts (Fig. 6B) . The amount of Oil Red-O extracted from treated Lmna þ/þ cells was higher than that extracted from untreated Lmna þ/þ cells, but the difference was not statistically significant (Fig. 6B) . To evaluate basal de novo lipogenesis of wild-type and Lmna 2/2 fibroblasts, we examined the ability of these cells to synthesize triglycerides using [ 3 H]oleate as substrate. Untreated Lmna 2/2 fibroblasts as well as Lmna 2/2 fibroblasts that have been treated for 9 days synthesized more triglycerides compared with similarly treated wild-type embryonic fibroblasts (Fig. 6C) .
De novo phospholipid synthesis remained unchanged between wild-type mouse embryonic fibroblasts and those lacking lamins A and C (Fig. 6D) . Our results show that embryonic fibroblasts that lack A-type lamins synthesized more intracellular lipid upon prolonged treatment with insulin, dexamethasone, IBMX and troglitazone. As insulin plays an important role in lipogenesis, we investigated response to insulin in Lmna þ/þ and Lmna 2/2 embryonic fibroblasts. Serum-starved cells were stimulated with insulin for 15 min, lysed and the amount of phosphorylated AKT1/PKBa (Ser473), a key component of the insulin-signaling pathway, was analyzed by immunoblotting. Serum-starved wild-type embryonic fibroblasts had virtually no AKT1 that was phosphorylated on Ser473 (Fig. 7A) . Incubation of these cells with insulin resulted in phosphorylation of AKT1 on Ser473 (Fig. 7A) . In contrast, serum-starved Lmna 2/2 fibroblasts showed a significant amount of phosphorylated AKT1 before addition of insulin, which further increased after stimulation with insulin (Fig. 7A) . The amount of phosphorylated AKT1 was similar in both cell types following insulin stimulation. Quantification of these results showed that serum-starved Lmna 2/2 fibroblasts contained four times phosphorylated AKT1, compared with similarly treated Lmna þ/þ fibroblasts (Fig. 7B) 
Possible mechanism of adipogenic inhibition
Our results plus those of others (21, 23) suggest that A-type lamins are inhibitors of myogenic and adipogenic differentiation. However, they may function differently in muscles than in adipose tissues. Stable overexpression of lamin A with an Emery -Dreifuss muscular dystrophy-causing mutation (R453W) in C2C12 myoblasts inhibits their differentiation into myotubes, but overexpression of a wild-type lamin A or lamin A with an FPLD-causing mutation (R482W) had almost no effect on differentiation of C2C12 cells (23) . Transient overexpression of lamin A with another Emery -Dreifuss muscular dystrophy-causing mutation (W520S) in C2C12 myoblasts also results in their inability to differentiate into myotubes and transient overexpression of wild-type lamin A slowed down the differentiation process (21) . Clues into how some lamin A mutations cause muscle-and fat-specific diseases may be provided by structural studies of the carboxyl terminal domain of A-type lamins. A part of the carboxyl terminal tail of lamins A and C forms an immunoglobulin domain type S (40, 41) . This domain is destabilized if lamin A/C residue 453 is mutated from arginine to tryptophan. However, the stability of this fold in A-type lamins with R482Q or R482W mutation resembles that of a wildtype lamin A/C (41). An unstable immunoglobulin fold domain may perturb the higher-order structure of the nuclear lamina and hence lead to inability of C2C12 cells to differentiate. In contrast, lamin A with a mutation at position 482 may not change the structure of nuclear lamina but may create an aberrant interaction with an unknown factor, leading to inability of 3T3-L1 cells to differentiate. The fact that overexpression of wild-type as well as mutant lamin A has an effect on adipogenic conversion suggests that mutations responsible for FPLD are 'gain of function' mutations and may result in higher binding affinity to a pro-adipogenic transcription factor therefore sequestering it at nuclear periphery and preventing it from activating its target genes. Overexpression of a wild-type lamin A may lead to 'gain of function' phenotype not because of an increased binding affinity to this protein but because of increased number of molecules with a normal binding affinity competing for it. The identity of this putative pro-adipogenic factor is not known. Exposure of 3T3-L1 cells to insulin, dexamethasone and IBMX activates a transcriptional cascade that results in the expression of several proteins involved in adipogenesis. After exposure to these factors, there is a transient expression of CCAAT/enhancer-binding proteins (C/EBPs) b and d that is thought to be the commitment step for adipogenic conversion (42) . Expression of C/EBPb and C/EBPd drives expression of PPARg, a nuclear receptor whose expression is primarily restricted to adipose tissue (43) , which in turn activates promoters of genes necessary for adipogenic conversion (44, 45) . Expression of SREBP-1C, a helix -loop -helix transcription factor that plays a role in adipogenesis as well as cholesterol and fatty acid biosynthesis (reviewed in 46) , is thought to be activated by insulin because its expression has been shown to be induced by AKT (47) . SREBP-1C has been shown to regulate PPARg2 transcription (48) and ligand synthesis (49) . PPARg2, in turn, is also able to activate expression of SREBP-1C (50). Expression of PPARg2 is decreased in cells overexpressing lamin A after stimulation for conversion into adipocytes. There is extensive evidence that expression PPARg2 is crucial for adipogenic conversion (51 -59) . In particular, reduction of PPARg2 expression in 3T3-L1 cells leads to significant reduction in their adipogenic capacity (60) . Expression of PPARg is controlled by several proteins and its activation affected by cofactors, including SREBP-1C. There is evidence that SREBP-1 can bind to lamin A in vitro (61) and recently it has been shown that SREBP-1 binds to farnesylated prelamin A (62). However, we did not detect an effect of lamin A overexpression on SREBP-1C mRNA in 3T3-L1 cells that did not differentiate into adipocytes. It is, therefore, possible that lamin A overexpression effects SREBP-1C on the post-transcriptional level. It has been proposed that activation of PPARg and SREBP-1C is accomplished by parallel pathways in adipocytes (63) , which could explain the presence of SREBP-1C mRNA and the absence of PPARg2 mRNA.
Embryonic fibroblasts lacking A-type lamins undergo adipogenesis more readily than wild-type embryonic fibroblasts. They also exhibit elevated basal levels of phosphorylated AKT1 compared with wild-type fibroblasts. It has been demonstrated that lamins A and C are important for proper function of protein phosphatase 2A (64) , a phosphatase that has been shown to dephosphorylate AKT1 (65) . Disregulation of protein phosphatase 2A in fibroblasts lacking A-type lamins may result in elevated levels of phosphorylated AKT1 after serum starvation. This increase may be responsible for elevated basal triglyceride synthesis in untreated Lmna 2/2 and Lmna 2/2 fibroblasts that have been previously treated to accumulated intracellular lipid. However, embryonic fibroblasts from Lmna þ/þ and Lmna 2/2 mice have similar amounts of phosphorylated AKT1 after exposure to insulin. Hence, A-type lamins do not affect AKT1 phosphorylation in response to insulin stimulation but rather the basal level of phosphorylated AKT1 protein. Therefore, the fact that fibroblasts lacking A-type lamins accumulate more lipid upon prolonged stimulation with insulin, dexamethasone, IBMX and troglitazone compared with similarly treated wild-type fibroblasts cannot be attributed to Lmna 2/2 cells being more insulin sensitive. We were unable to detect any defect in AKT1 phosphorylation after insulin stimulation of 3T3-L1 cells overexpressing wild-type or mutant lamin A (data not shown). Hence, we conclude that another presently unidentified mechanism must be responsible for elevated lipid accumulation of Lmna 2/2 cells. Our studies examining the possible effects of A-type lamins on AKT1 phosphorylation are preliminary and require more supporting evidence to be conclusive.
Limitations of the tissue culture model and implications for human pathology
Human subjects with FPLD begin experiencing fat loss generally with onset of puberty and have normal peripheral adipose tissue until then. Therefore, the disease may be due to the inability to maintain the differentiated state of the tissue and not an inability to acquire it in the first place. In FPLD, subjects lose subcutaneous fat, but retain visceral fat (66) . The difference between visceral and subcutaneous fat has been well documented (67, 68) but poorly understood. Even though 3T3-L1 cell line is an accepted tissue culture model of subcutaneous fat tissue (69) , it is also known that 3T3-L1 cells behave differently when injected in visceral or subcutaneous fat areas (70) . Hence, our tissue culture model, as all tissue culture models of disease, lacks the context of a whole organism.
Our results reflect the results of overexpression of wild-type and mutant lamin A, which does not represent the disease state, in which affected subjects apparently have normal levels of expression of A-type lamins (71) . Considering that human subjects likely express equal levels of mutant and wild-type A-type lamins in FPLD, the lamin A mutants that cause FPLD are likely 'overactive' in the aspect of lamin A function that negatively regulates adipocyte differentiation. In our in vitro models, we used cells that either had too much or no lamin A (and lamin C). Neither cells expressing too much wild-type lamin A nor cells expressing too much of the FPLD mutants differentiated into adipocytes. In vivo, the mutants likely have a more pronounced inhibitory effect on adipogenesis and they inhibit the process even when expressed at normal levels. Finally, as overexpression of wild-type lamin A is inhibitory to adipogenesis, it is imaginable that subtle differences and polymorphisms in the LMNA promoter or coding sequence in humans may be partially responsible for the heterogeneity of metabolic syndrome or obesity phenotype. This intriguing hypothesis could be studied in large human populations.
In a recent paper, Kudlow et al. (72) reported that overexpression of wild-type lamin A or lamin A with FPLDcausing mutations did not inhibit 3T3-L1 differentiation, in contrast to what we have reported here. Kudlow et al. (72) also observed that prelamin A accumulation did not inhibit differentiation of 3T3-L1 preadipocytes, in contrast to that reported by Capanni et al. (62) , who treated 3T3-L1 cells with mevinolin as well farnesyl transferase inhibitors to accumulate prelamin A. Kudlow et al. (72) only studied populations of 3T3-L1 cells transduced with retroviral vectors for lamin A overexpression, whereas we also carried out our experiments in multiple clonal populations of 3T3-L1 cells and obtained similar results. Our data in fibroblasts other than 3T3-L1 preadipocytes, namely embryonic fibroblasts from lamin A/C 'knockout' mice, also support the fact that A-type lamins are inhibitors of lipid accumulation. The reasons for the conflicting results in 3T3-L1 cells, while not readily apparent, will be clarified with additional studies and comparisons of the exact culture and differentiation methods used.
MATERIALS AND METHODS
Plasmid construction
Complementary DNAs encoding human emerin, wild-type prelamin A (lamin A) and prelamin A with R482Q (lamin A R482Q) or R482W (lamin A R482W) mutations fused to the sequence encoding the flag epitope were cloned into pSVK3 (Amersham Biosciences) as previously described (73, 74) . From these clones, flag-tagged lamin A cDNAs were excised using EcoRI and XhoI restriction endonucleases and ligated into pIND (Invitrogen) digested with these enzymes. Flag-tagged emerin cDNA was excised from pSVK3 with BamHI and XhoI restriction endonucleases and ligated into the same restriction sites of pIND. Complementary DNAs encoding wild-type and mutant lamin A fused to the flag epitope sequence were also cloned into pMIG (75) using BamHI and XhoI restriction endonucleases. To express proteins without flag epitopes, DNA sequences lacking the flag-coding region were excised from pSVK3 with SmaI and XhoI restriction endonucleases and ligated into pMIG vector digested with HpaI and XhoI.
Cell culture, transfection and cell line selection 3T3-L1 cells (American Tissue Culture Collection) were grown in DMEM supplemented with 10% fetal bovine serum (FBS) at 10% CO 2 and 378C. For transfection, cells were grown to 70% confluency in 100 mm plates and co-transfected with pIND constructs and pVgRXR (Invitrogen) using Lipofectamine 2000 (Invitrogen) according to the manufacturer's directions. The next day, medium containing Lipofectamine 2000 was replaced by DMEM supplemented with 10% FBS, 300 mg/ml of Zeocin (Invitrogen) and 600 mg/ml of Geneticin (Invitrogen) for 20 days. Surviving cells were transferred to 96-well plates at a seeding density of 0.5 cell/well and tested for expression of flag-tagged proteins by indirect immunofluorescence microscopy using an anti-flag antibody. Cells that expressed the proteins were further grown and aliquots were frozen. Although pIND and pVgRXR comprise a muristerone-A-inducible expression system, in our experiments, the system was 'leaky' and transcription of flag-tagged lamins as well as flag-tagged emerin occurred without addition of muristerone A.
Mouse embryonic fibroblasts from Lmna 2/2 and Lmna þ/þ mice have been previously described (67) . These fibroblasts were grown in DMEM supplemented with 10% FBS in 5% CO 2 and 378C. 293T cells were grown in DMEM supplemented with 10% FBS in 5% CO 2 and 378C.
Cell differentiation
3T3-L1 cells were grown to confluency in DMEM supplemented with 10% FBS. After 2 days, medium was switched to DMEM supplemented with 10% FBS, 0.5 mM IBMX (Sigma-Aldrich), 1 mM dexamethasone (Sigma-Aldrich) and 1 mM insulin (Sigma-Aldrich) for 48 h. In all cases, after 48 h, this medium was replaced by DMEM supplemented with 10% FBS and 1 mM insulin for additional 3 or 5 days. Geneticin and Zeocin were always present in the medium. Mouse embryonic fibroblasts were grown to confluency in DMEM supplemented with 10% FBS. After 2 days, medium was switched to DMEM with 10% FBS, 0.5 mM IBMX, 1 mM dexamethasone, 5 mM insulin and 1 mM troglitazone (BioMall) for 48 h. In all cases, after 48 h, medium was replaced with DMEM with 10% FBS supplemented with 5 mM insulin and 1 mM troglitazone for another 7 days.
Oil Red-O staining and extraction
Intracellular lipid accumulation was monitored by Oil Red-O (Sigma-Aldrich) staining. A 0.5% (w/v) solution of Oil Red-O was prepared in 60% isopropanol. Cells were washed twice with phosphate-buffered saline (PBS), fixed in 4% paraformaldehyde for 20 min at 48C, washed once with PBS and once with 60% isopropanol. Plates were then incubated with Oil Red-O solution at room temperature for 5 min, rinsed with 60% isopropanol and overlaid with PBS. Plates were scanned into a G3 Macintosh computer (Apple Computer) using an Expression 636 flatbed scanner (Epson) using 3Â or 1Â enlargement of actual size. For semiquantitative analysis of Oil Red-O staining, dye was extracted by incubating stained cells with 4% SDS in 60% isopropanol at room temperature for 15 min. Optical density of the extracted Oil Red-O was measured in a DU-6 spectrophotometer (Beckman) at wavelength of 520 nm.
Retroviral production and infection
293T cells were grown to 70% confluency in DMEM supplemented with 10% FBS and were co-transfected with 15 mg of pMIG constructs along with 10 mg of pVSV-G and pCL-Eco (a kind gift of Dr Jonathan Barach, Columbia University) using Lipofectamine 2000. Medium that contained viral particles was collected 24 h after transfection, filtered through a 0.8-mm filter, supplemented with 8 mg/ml of polyprene and stored at 48C. For infection, 3T3-L1 cells were grown to 50% confluency in 6-well plates in DMEM supplemented with 10% FBS. Growth medium was supplemented with medium containing viral particles at 1:1 (v/v) ratio and added to 3T3-L1 cells for 24 -36 h. Infected cells expressing GFP were isolated by fluorescence-activated cell sorting.
Antibodies and immunofluorescence microscopy
Rabbit polyclonal antibodies raised against lamins A and B1 were used as described previously (76) . Anti-flag M5 mouse monoclonal antibody was purchased from Sigma-Aldrich. Anti-AKT1/PKBa antibody was purchased from Santa Cruz Biotechnology. Anti-phospho-AKT1/PKBa (Ser473), clone 11E6 was purchased from Upstate Cell Signaling Solutions. Affinity purified, secondary antibodies were purchased from Jackson ImmunoResearch Laboratories. Cells were grown in 2-, 4-or 16-well chamber slides and fixed with 100% methanol for 10 min at 2208C. Cells were then incubated with primary antibodies for 2 h, washed and incubated with secondary antibodies for 1 h. Immunofluorescence microscopic analysis was done on Zeiss LSM 510 confocal laser scanning system attached to a Zeiss Axiovert 200 M inverted microscope (Carl Zeiss, Inc.).
Fluorescence-activated cell-sorting analysis
Cells were grown to 80% confluency, trypsinized, washed with PBS and resuspended in PBS at 2 Â 10 5 cells/ml. Cells expressing GFP were sorted on Becton Dickinson FACSAria (BD Sciences) set to select highest 40% of GFP-expressing cells. Selected cells were collected and pelleted at 2000g, resuspended in DMEM supplemented with 10% FBS and grown in 6-well plates for further analysis.
De novo lipogenesis assay
Cells, cultured in 6-or 12-well plates, were incubated in DMEM supplemented with 1% free fatty-acid-free bovine serum albumin and 5 mCi/ml of [ 3 H]oleate for 4 h. Cells were then washed three times with PBS supplemented with 0.2% free fatty-acid-free bovine serum albumin and then twice with PBS. Cellular lipids were extracted three times with 1 ml of hexane:isopropanol (3:2, v/v) solution. Extracted lipids were dried under N 2 and resuspended in 0.15 ml of chloroform:methanol (2:1, v/v) and spotted onto silicacoated TLC plates (Fisher) 
Insulin response assay and immunoblotting
Mouse embryonic fibroblasts were grown to 80% confluency and serum starved for 6-8 h in DMEM. Cells were then transferred to medium supplemented with 100 nM insulin for 15 min. To prepare whole cell lysates, cells were washed with PBS, scraped from plates and resuspended in 50 mM Tris -HCl (pH 7.4), 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 1 mM sodium orthovanadate and 1 mM sodium fluoride. An amount of 25 or 50 mg of cellular protein was loaded onto 10% or 4 -15% gradient acrylamide gels (Biorad Laboratories) and separated by electrophoresis. Proteins were transferred onto a nitrocellulose membrane (Biorad Laboratories) and membranes were incubated with primary and horseradish-peroxidase-linked secondary antibodies. Chemiluminescence was detected using ECL Kit (Amersham) according to the manufacturer's instructions. Scion Image software (http://www.scioncorp.com) was used for quantitative analysis of phosphorylated AKT1 and total AKT1 signals.
Materials
Unless otherwise specified, routine chemical reagents were obtained from Sigma-Aldrich. Tissue culture reagents were obtained from Invitrogen.
Human
